- $6.00bn
- $6.05bn
- $2.44bn
- 94
- 52
- 95
- 95
Annual income statement for Itron, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,173 | 1,982 | 1,796 | 2,174 | 2,441 |
| Cost of Revenue | |||||
| Gross Profit | 602 | 573 | 522 | 714 | 839 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,184 | 2,061 | 1,803 | 2,045 | 2,177 |
| Operating Profit | -10.4 | -79.3 | -7.44 | 129 | 264 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -56.6 | -124 | -15.7 | 127 | 285 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -56.9 | -78.3 | -9.55 | 98.3 | 241 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -58 | -81.3 | -9.73 | 96.9 | 239 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -58 | -81.3 | -9.73 | 96.9 | 239 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.14 | 0.08 | 0.252 | 2.87 | 5.12 |